Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-23-075942

Options or other derivatives

  • Director acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Swirsky Douglas J Director 2023-06-28 Grant or award · Stock option (right to buy) +37,500 71,925 D
Loading xslF345X04/tm2320030-5_4seq1.xml…